India to Peru: Lapatinib Export Trade Route
India has recorded 1 verified shipments of Lapatinib exported to Peru, representing a combined trade value of $85.5K USD. This corridor is served by 1 active Indian exporters, with an average shipment value of $85.5K USD. The leading Indian exporter is GLOBELA PHARMA PRIVATE LIMITED, which accounts for 100% of total export value with 1 shipments worth $85.5K USD. On the buying side, M S DROGUERIA PERU SAC DROPESAC is the largest importer in Peru with $85.5K USD in purchases. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Peru Lapatinib corridor is one of India's established pharmaceutical export routes, with 1 shipments documented worth a combined $85.5K USD. The route is dominated by GLOBELA PHARMA PRIVATE LIMITED, which alone accounts for roughly 100% of all export value, reflecting the consolidated nature of India's lapatinib manufacturing sector.
Across 1 active suppliers, the average shipment value stands at $85.5K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (65%) and air (15%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.
Shipment activity peaks during October–December, with an average transit time of 27 days port-to-port. The route has recorded an annual growth rate of 27.1%, placing it at rank #5 among India's top lapatinib export destinations globally.
On the import side, key buyers of Indian lapatinib in Peru include M S DROGUERIA PERU SAC DROPESAC. M S DROGUERIA PERU SAC DROPESAC is the single largest importer with 1 shipments valued at $85.5K USD.
Route Characteristics
- Average transit27 days
- Peak seasonQ4
- Primary modeMulti-modal
- Top portBombay Air Cargo
Market Position
- Global rank#5
- Annual growth+27.1%
- Demand growth+22.8%
- Regulatory ease65/100
Top 10 Indian Lapatinib Exporters to Peru
Showing top 10 of 1 Indian suppliers exporting Lapatinib to Peru, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | GLOBELA PHARMA PRIVATE LIMITED Avg $85.5K per shipment | 1 | $85.5K | 100.0% |
This table shows the top 10 of 1 Indian companies exporting lapatinib to Peru, ranked by total trade value. The listed exporters are: GLOBELA PHARMA PRIVATE LIMITED. GLOBELA PHARMA PRIVATE LIMITED is the dominant supplier with 1 shipments worth $85.5K USD, giving it a 100% market share.
Top 10 Lapatinib Importers in Peru
Showing top 10 of 1 known buyers in Peru receiving Lapatinib shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian lapatinib in Peru include M S DROGUERIA PERU SAC DROPESAC. The largest importer is M S DROGUERIA PERU SAC DROPESAC, accounting for $85.5K USD across 1 shipments — representing 100% of all lapatinib imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | M S DROGUERIA PERU SAC DROPESAC | 1 | $85.5K | 100.0% |
Top 10 Lapatinib Formulations Imported by Peru
Showing top 10 of 1 product formulations shipped on the India to Peru Lapatinib route, ranked by trade value
Peru imports a wide range of lapatinib formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — HARMLESS MEDICINES FOR HUMAN CONSUMPTION LAPAGLOB LAPATINIB DITOSYLATE TABLETS 250MG BATCH NO 25GST060 TO 61 10 X 1 — accounts for $85.5K USD across 1 shipments. A total of 1 product variants have been identified in the shipment records.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | HARMLESS MEDICINES FOR HUMAN CONSUMPTION LAPAGLOB LAPATINIB DITOSYLATE TABLETS 250MG BATCH NO 25GST060 TO 61 10 X 1 | 1 | $85.5K | 100.0% |
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Balanced freight mix — 65% sea for bulk, 15% air for urgent orders.
Top Ports of Origin
Bombay Air Cargo handles the highest volume with 1 shipments. Transit time averages 27 days by sea.
Market Dynamics
India's lapatinib exports to Peru are driven primarily by a handful of large-scale manufacturers. GLOBELA PHARMA PRIVATE LIMITED with 1 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 1 active exporters signals a competitive but concentrated market — buyers in Peru benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — GLOBELA PHARMA PRIVATE LIMITED — together account for 100% of total trade value on this route. The average shipment value of $85.5K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.
On the buying side, M S DROGUERIA PERU SAC DROPESAC is the largest importer with 1 shipments worth $85.5K USD — representing 100% of all lapatinib imports from India on this route.
Route Statistics
- Trade Volume
- $85.5K
- Avg. Shipment
- $85.5K
- Suppliers
- 1
- Buyers
- 1
- Transit (Sea)
- ~27 days
- Annual Growth
- +27.1%
Other Lapatinib Routes
Unlock the Full India to Peru Lapatinib Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 1 shipments on this route.
Frequently Asked Questions — India to Peru Lapatinib Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Lapatinib to Peru?
The leading Indian exporters of Lapatinib to Peru are GLOBELA PHARMA PRIVATE LIMITED. GLOBELA PHARMA PRIVATE LIMITED holds the largest market share at approximately 100% of total trade value on this route.
Q What is the total value of Lapatinib exports from India to Peru?
India exports Lapatinib to Peru worth approximately $85.5K USD across 1 recorded shipments. The average value per shipment is $85.5K USD.
Q Which ports does India use to ship Lapatinib to Peru?
The most active port of origin is Bombay Air Cargo with 1 shipments. Indian exporters primarily use a mix of sea and air freight for this route, with 65% of shipments going by sea and 15% by air.
Q How long does shipping take from India to Peru for Lapatinib?
The average transit time for Lapatinib shipments from India to Peru is approximately 27 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during October–December.
Q Is the India to Peru Lapatinib trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 27.1% with demand growth tracking at 22.8%. The route is ranked #5 among India's top Lapatinib export destinations globally.
Q How many suppliers are active on the India to Peru Lapatinib route?
There are currently 1 active Indian suppliers exporting Lapatinib to Peru. The market is moderately concentrated with GLOBELA PHARMA PRIVATE LIMITED accounting for 100% of total shipment value.
Q Who are the main importers of Lapatinib from India in Peru?
The leading importers of Indian Lapatinib in Peru include M S DROGUERIA PERU SAC DROPESAC. M S DROGUERIA PERU SAC DROPESAC is the largest buyer with 1 shipments worth $85.5K USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to Peru export trade corridor identified from Indian Customs (DGFT) records for Lapatinib.
- 2.Supplier/Buyer Matching: 1 Indian exporters and 1 importers in Peru matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 1 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
1 Verified Shipments
1 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists